Table 1.
Laboratory markers | Normal reference range | First tests | Last tests | ||||
---|---|---|---|---|---|---|---|
Survivors | Non-survivors | P value | Survivors | Non-survivors | P value | ||
WBC, ×109/L | 3.5–9.5 | 6.22 | 10.86 ↑ | < 0.001 ** | 6.34 | 14.72 ↑ | < 0.001 ** |
Lymphocyte count, ×109/L | 0.8–4 | 1.04 | 0.62 ↓ | < 0.001 ** | 1.33 | 0.55 ↓ | < 0.001 ** |
Lymphocyte percentage, % | 20–40 | 20.82 | 6.70 ↓ | < 0.001 ** | 24.31 | 4.56 ↓ | < 0.001 ** |
Neutrophil count, ×109/L | 2–7 | 4.74 | 9.77 ↑ | < 0.001 ** | 4.39 | 13.65 ↑ | < 0.001 ** |
Neutrophil percentage, % | 50–70 | 71.39 ↑ | 88.14 ↑ | < 0.001 ** | 65.22 | 91.31 ↑ | < 0.001 ** |
Monocyte count, ×109/L | 0.12–1.2 | 0.37 | 0.41 | 0.457 | 0.45 | 0.40 | 0.378 |
Monocyte percentage, % | 3–12 | 6.53 | 4.47 | 0.002 * | 7.62 | 3.27 | < 0.001 ** |
Eosinophil count, ×109/L | 0.02–0.5 | 0.05 | 0.03 | 0.292 | 0.13 | 0.05 | 0.001 * |
Eosinophil percentage, % | 0.5–5 | 0.88 | 0.42 ↓ | 0.015 * | 2.34 | 0.63 | < 0.001 ** |
Basophil count, ×109/L | 0–0.1 | 0.02 | 0.03 | 0.35 | 0.03 | 0.03 | 0.682 |
Basophil percentage, % | 0–1 | 0.37 | 0.27 | 0.152 | 0.50 | 0.28 | 0.008 * |
Platelet count, × 109/L | 125–350 | 214.66 | 178.77 | 0.1 | 232.63 | 125.48 | < 0.001 ** |
MPV, fL | 7–11 | 9.23 | 10.01 | 0.003 * | 9.20 | 11.11 ↑ | < 0.001 ** |
PDW | 15–17 | 16.18 | 16.63 | < 0.001 ** | 16.14 | 16.74 | < 0.001 ** |
Thrombocytocrit, % | 0.1–0.282 | 0.19 | 0.18 | 0.41 | 0.21 | 0.14 | < 0.001 ** |
Platelet-large cell count, ×109/L | 30–90 | 43.45 | 45.79 | 0.606 | 47.80 | 39.58 | 0.066 |
Platelet-large cell percentage, % | 11–45 | 21.60 | 26.75 | 0.003 * | 21.22 | 34.67 | < 0.001 ** |
hs-CRP, mg/L | < 3 | 59.58 ↑ | 191.76 ↑ | < 0.001 ** | 22.36 ↑ | 248.49 ↑ | < 0.001 ** |
PCT, ng/mL | 0–0.05 | 0.30 ↑ | 0.89 ↑ | 0.019 * | 0.28 ↑ | 23.36 ↑ | 0.009 * |
IL-6, pg/ml | 0–7 | 40.65 ↑ | 76.10 ↑ | 0.137 | 111.77 ↑ | 1012.76 ↑ | 0.13 |
PT, s | 11–15 | 15.58 ↑ | 23.15 ↑ | 0.089 | 14.76 | 19.57 ↑ | 0.002 * |
PT-INR | 0.8–1.2 | 1.22 ↑ | 2.19 ↑ | 0.132 | 1.14 | 1.65 ↑ | 0.003 * |
PTA, % | 80–150 | 78.48 ↓ | 52.83 ↓ | < 0.001 ** | 90.39 | 57.67 ↓ | < 0.001 ** |
TT, s | 13–20 | 20.17 ↑ | 19.64 | 0.864 | 17.59 | 18.94 | 0.139 |
aPTT, s | 28–44 | 42.52 | 46.61 ↑ | 0.285 | 41.62 | 47.07 ↑ | 0.245 |
Fibrinogen, g/L | 2–4 | 4.38 ↑ | 5.07 ↑ | 0.098 | 4.13 ↑ | 4.54 ↑ | 0.248 |
D-dimer, μg/mL | 0–0.5 | 2.83 ↑ | 9.92 ↑ | 0.002 * | 1.58 ↑ | 12.24 ↑ | < 0.001 ** |
FDP, μg/mL | 0–5 | 15.55 ↑ | 86.68 ↑ | 0.014 * | 7.32 ↑ | 75.67 ↑ | < 0.001 ** |
Antithrombin III, % | 80–120 | 91.71 | 86.19 | 0.179 | 95.97 | 75.21 ↓ | 0.001 * |
RBC, × 1012 | 3.5–5.5 | 4.11 | 3.86 | 0.143 | 3.80 | 3.21 ↓ | 0.003 * |
Haemoglobin #, g/L | 124.2–165.3 | 122.34 ↓ | 115.27 ↓ | 0.164 | 111.85 ↓ | 94.73 ↓ | 0.005 * |
Haematocrit, % | 40–54 | 37.97 ↓ | 36.06 ↓ | 0.217 | 35.37 ↓ | 30.31 ↓ | 0.006 * |
MCV, fL | 82–100 | 92.61 | 92.89 | 0.827 | 93.41 | 94.43 | 0.412 |
MCH, pg | 27–34 | 29.66 | 29.89 | 0.621 | 29.49 | 29.36 | 0.775 |
MCHC, g/L | 316–354 | 320.24 | 321.52 | 0.574 | 315.61 ↓ | 310.94 ↓ | 0.109 |
RDW-CV, % | 11.5–14.5 | 13.04 | 12.93 | 0.618 | 13.65 | 13.44 | 0.471 |
RDW-SD, fL | 35–56 | 42.21 | 41.66 | 0.474 | 44.40 | 44.00 | 0.689 |
nRBC, ×109/L | 0.01 ↑ | 0.01 ↑ | 0.981 | 0 | 0.06 ↑ | 0.033 * | |
nRBC%, /100WBC | 0.15 ↑ | 0.04 ↑ | 0.632 | 0 | 0.29 ↑ | 0.011 * | |
Ret, ×1012 | 0.02–0.2 | 0.04 | 0.05 | 0.488 | 0.07 | 0.06 | 0.208 |
Ret%, % | 0.3–3 | 1.09 | 1.31 | 0.133 | 1.98 | 1.89 | 0.793 |
lf-Ret%, % | 80–100 | 93.13 | 90.54 | 0.035 * | 91.54 | 87.72 | 0.004 * |
mf-Ret%, % | 0–20 | 6.38 | 8.93 | 0.011 * | 7.96 | 10.71 | 0.009 * |
hf-Ret%, % | 0–5 | 0.49 | 0.53 | 0.893 | 0.51 | 1.57 | 0.025 * |
IRF, % | 0–25 | 6.87 | 9.46 | 0.035 * | 8.46 | 12.28 | 0.004 * |
SpO2, % | 95–98 | 90.35 ↓ | 90.72 ↓ | 0.926 | 94.89 ↓ | 87.54 ↓ | 0.119 |
TCO2, mmol/L | 22–29 | 21.85 ↓ | 19.60 ↓ | 0.333 | 27.88 | 23.48 | 0.002 * |
PaO2, mmHg | 80–105 | 96.64 | 76.10 ↓ | 0.205 | 101.79 | 87.55 | 0.351 |
PaCO2, mmHg | 35–45 | 33.51 ↓ | 28.45 ↓ | 0.095 | 45.16 ↑ | 48.43 ↑ | 0.539 |
Acidity-basicity | 7.35–7.45 | 7.40 | 7.44 | 0.268 | 7.39 | 7.31 ↓ | 0.035 * |
ABR, mmol/L | 22–27 | 20.82 ↓ | 18.72 ↓ | 0.351 | 26.49 | 22.01 | 0.001 * |
BEEcf, mmol/L | -2-3 | −3.43 ↓ | −4.95 ↓ | 0.529 | 1.96 | −3.51 ↓ | 0.001 * |
PCO2, mmol/L | 22–29 | 20.57 ↓ | 17.58 ↓ | 0.009 * | 22.36 | 19.40 ↓ | 0.002 * |
PUA, μmol/L | 210–430 | 330.99 | 372.57 | 0.5 | 290.85 | 454.43 ↑ | 0.007 * |
Plasma creatinine, μmol/L | 53–123 | 322.79 ↑ | 459.80 ↑ | 0.303 | 236.91 ↑ | 389.64 ↑ | 0.081 |
PUN, mmol/L | 2.9–8.2 | 11.01 ↑ | 17.86 ↑ | 0.093 | 9.12 ↑ | 25.45 ↑ | < 0.001 ** |
eGFR, mL/min/1.73m2 | > 90 | 87.85 ↓ | 69.88 ↓ | 0.168 | 101.30 ↑ | 46.13 ↓ | < 0.001 ** |
Cystatin C, mg/L | 0–1.5 | 2.48 ↑ | 3.28 ↑ | 0.24 | 2.38 ↑ | 3.67 ↑ | 0.03 * |
Sodium, mmol/L | 135–145 | 139.43 | 140.32 | 0.39 | 139.85 | 144.40 | 0.034 * |
Potassium, mmol/L | 3.5–5.5 | 4.06 | 4.11 | 0.828 | 4.25 | 4.67 | 0.096 |
Total calcium, mmol/L | 2.08–2.6 | 2.10 | 1.97 ↓ | 0.027 * | 2.19 | 1.94 ↓ | < 0.001 ** |
Phosphorus, mmol/L | 1–1.6 | 1.23 | 1.50 | 0.234 | 1.27 | 1.69 ↑ | 0.029 * |
Magnesium, mmol/L | 0.6–1.1 | 0.97 | 1.01 | 0.562 | 0.90 | 1.02 | < 0.001 ** |
Chlorine, mmol/L | 95–110 | 103.52 | 104.18 | 0.695 | 104.00 | 105.77 | 0.437 |
hs-cTnI, ng/mL | 0–0.023 | 0.03 ↑ | 0.01 | 0.313 | 0.02 | 0.37 ↑ | 0.166 |
Myoglobin, ng/mL | 23–112 | 195.78 ↑ | 342.42 ↑ | 0.126 | 233.33 ↑ | 547.84 ↑ | 0.005 * |
NT-proBNP, ng/L | 0–900 | 5179.35 ↑ | 6173.35 ↑ | 0.784 | 6204.18 ↑ | 12,539.35 ↑ | 0.156 |
LDH, U/L | 80–285 | 276.57 | 465.15 ↑ | < 0.001 ** | 203.73 | 602.65 ↑ | < 0.001 ** |
HCA, μmol/L | 0–15 | 12.96 | 10.02 | 0.242 | 14.23 | 12.81 | 0.606 |
CK, U/L | 50–310 | 130.39 | 373.00 ↑ | 0.192 | 70.34 | 402.55 ↑ | 0.006 * |
CKI, ng/mL | 0–7.2 | 8.15 ↑ | 5.60 | 0.466 | 3.84 | 25.03 ↑ | 0.041 * |
Total bilirubin, μmol/L | 0–25 | 13.44 | 17.45 | 0.351 | 14.89 | 21.59 | 0.292 |
Direct bilirubin, μmol/L | 0–6.84 | 6.98 ↑ | 8.09 ↑ | 0.758 | 5.82 | 14.27 ↑ | 0.09 |
Total bile acid, μmol/L | 0–10 | 11.10 ↑ | 5.44 | 0.51 | 5.16 | 7.78 | 0.276 |
Prealbumin, mg/L | 160–450 | 179.61 | 87.87 ↓ | < 0.001 ** | 224.84 | 98.51 ↓ | < 0.001 ** |
Total protein, g/L | 60–85 | 70.26 | 65.30 | 0.01 * | 72.05 | 62.88 | 0.002 * |
Albumin, g/L | 34–55 | 36.60 | 30.27 ↓ | < 0.001 ** | 36.64 | 26.99 ↓ | < 0.001 ** |
Globulin, g/L | 20–40 | 33.65 | 35.04 | 0.304 | 35.40 | 35.89 | 0.795 |
AGR | 1.2–2.4 | 1.11 ↓ | 0.89 ↓ | 0.001 * | 1.08 ↓ | 0.80 ↓ | < 0.001 ** |
ALT, U/L | 9–50 | 32.19 | 34.57 | 0.741 | 27.47 | 46.62 | 0.202 |
AST, U/L | 15–40 | 34.49 | 47.91 ↑ | 0.065 | 26.75 | 82.59 ↑ | 0.015 * |
ALP, U/L | 45–125 | 64.30 | 77.17 | 0.243 | 68.48 | 98.29 | 0.004 * |
GGT, U/L | 10–60 | 52.87 | 64.15 ↑ | 0.511 | 45.22 | 51.70 | 0.476 |
Cholinesterase, U/L | 4500–12,000 | 5844.80 | 4521.15 | 0.003 * | 5849.76 | 3611.55 ↓ | < 0.001 ** |
Glucose, mmol/L | 3.9–6.1 | 6.93 ↑ | 8.11 ↑ | 0.22 | 6.04 | 8.39 ↑ | < 0.001 ** |
Triglyceride, mmol/L | < 2.3 | 1.67 | 1.45 | 0.527 | 1.65 | 2.15 | 0.044 * |
Total cholesterol, mmol/L | 0–5.1 | 3.92 | 3.26 | 0.015 * | 4.34 | 2.92 | < 0.001 ** |
HDL-C, mmol/L | 0.8–2 | 0.95 | 0.86 | 0.323 | 1.07 | 0.79 ↓ | 0.006 * |
non-HDL-C, mmol/L | 2.2–5.8 | 2.98 | 2.40 | 0.029 * | 3.27 | 2.13 ↓ | < 0.001 ** |
LDL-C, mmol/L | 0–3.36 | 2.46 | 1.91 | 0.021 * | 2.80 | 1.50 | < 0.001 ** |
sdLDL-C, mmol/L | 0.23–1.37 | 0.73 | 0.48 | 0.028 * | 0.92 | 0.47 | 0.001 * |
Apolipoprotein A1, g/L | 1–1.6 | 0.90 ↓ | 0.76 ↓ | 0.057 | 1.07 | 0.61 ↓ | < 0.001 ** |
Apolipoprotein B, g/L | 0.6–1.1 | 0.84 | 0.73 | 0.087 | 0.87 | 0.68 | 0.006 * |
Lipoprotein(a), mg/L | 0–300 | 185.60 | 189.68 | 0.938 | 208.12 | 133.05 | 0.129 |
↑ above normal reference range. ↓ below normal reference range. * P value less than 0.05 and more than 0.001. ** P value less than 0.001. # The normal reference range of haemoglobin was calculated based on the number of female and male, cause the normal reference range of haemoglobin of female was 115–150 g/L, the normal reference range of haemoglobin of male was 130–175 g/L. ABR Actual bicarbonate radical; AGR Albumin-globulin ratio; ALP Alkaline phosphatase; ALT Alanine aminotransferase; aPTT Activated partial thromboplastin time; AST Aspartate aminotransferase; BEEcf Base excess in the extracellular fluid compartment; CK Creatine kinase; CKI Creatine kinase isoenzymes; eGFR Estimated glomerular filtration rate; FDP Fibrin (ogen) degradation product; GGT γ-Glutamyl transferase; HCA Homocysteic acid; HDL-C High-density lipoprotein cholesterol; hf-Ret% High fluorescent reticulocyte percentage; hs-CRP Hypersensitive C-reactive protein; hs-cTnI High-sensitivity cardiac troponin I; IL-6 Interleukin-6; IRF Immature reticulocyte fraction; LDH Lactate dehydrogenase; LDL-C Low-density lipoprotein cholesterol; lf-Ret% Low fluorescent reticulocyte percentage; MCH Mean corpuscular volume; MCHC Mean corpuscular haemoglobin concentration; MCV Mean corpuscular volume; mf-Ret% Middle fluorescent reticulocyte percentage; MPV Mean platelet volume; non-HDL-C Nonhigh-density lipoprotein cholesterol; nRBC Nucleated red blood cell count; nRBC% Nucleated red blood cell percentage; NT-proBNP N-terminal pro B-type natriuretic peptide; PaCO2 Partial pressure of carbon dioxide; PaO2 Partial pressure of oxygen; PCO2 Plasma carbon dioxide; PCT Procalcitonin; PDW Platelet distribution width; PT Prothrombin time; PTA Prothrombin activity; PT-INR Prothrombin international normalized ratio; PUA Plasma uric acid; PUN Plasma urea nitrogen; RBC Red blood cell count; RDW-CV Red blood cell distribution width - coefficient of variation; RDW-SD Red blood cell distribution width - standard deviation; Ret Reticulocyte count; Ret% Reticulocyte percentage; sdLDL-C Small-dense low-density lipoprotein cholesterol; SpO2 Oxygen saturation; TCO2 Total carbon dioxide; TT Thrombin time; WBC White blood cell count